Liquid Biopsy for Biomarker Testing in Non-Small Cell Lung Cancer: A European Perspective

Liquid Biopsy for Biomarker Testing in Non-Small Cell Lung Cancer: A European Perspective

The development of targeted therapies has improved survival rates for patients with advanced non-small cell lung cancer (NSCLC). However, tissue biopsy is unfeasible or inadequate in many patients, limiting biomarker testing and access to targeted therapies. The increasing numbers of established and...

Full description

Bibliographic Details
Main Authors: Umberto Malapelle, Marcello Tiseo, Ana Vivancos, Joshua Kapp, M. Josè Serrano, Markus Tiemann
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Journal of Molecular Pathology
Subjects:
cfDNA
ctDNA
liquid biopsy
next-generation sequencing
non-small cell lung cancer
molecular diagnostics
Online Access:https://www.mdpi.com/2673-5261/2/3/22

Internet

https://www.mdpi.com/2673-5261/2/3/22

Similar Items